ASHLEY SCHAEFER: Open Payments
NPI 1942452511 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,144 in 117 payments from 17 companies in 2025. Trend: 2023 $2,295 · 2024 $1,755 · 2025 $2,144
Food & beverage: $1,990Education: $153
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $616 |
| Janssen Biotech, Inc. | 17 | $302 |
| UCB, Inc. | 9 | $285 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 17 | $211 |
| Regeneron Healthcare Solutions, Inc. | 7 | $153 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| Amgen Inc. | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Lilly USA, LLC | 2 | $66 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $58 |
Products named: SKYRIZI, TREMFYA, Bimzelx, Cabtreo, DUPIXENT, Otezla, RINVOQ, Sotyktu.
Industry payments across MA — which companies pay providers there.
